Hypertension Research最新文献

A retrospective cohort study with 4396 twins who registered before 13 gestational weeks and delivered between January 2013 and December 2020 at Shanghai First Maternity and Infant Hospital, China, was conducted to clarify causal associations between inter-twin estimated fetal weight discordance and preeclampsia. Ultrasound measurements of fetal biometry were collected until the confirmation of preeclampsia diagnosis or the termination of pregnancy (when preeclampsia did not occur). Inter-twin discordance was divided into binary variables using cut-offs of 10%, 15%, and 20%. The associations between inter-twin discordance and preeclampsia were analyzed using generalized estimating equations and group-based trajectory modeling methods. The incidence of preeclampsia was 13.9%, among which 21.8% of cases were diagnosed at early onset and 55.3% at a severe stage. Inter-twin discordance based on estimated fetal weight during pregnancy was positively associated with preeclampsia. The associations were robust and constant by treating the discordance as continuous and binary. Two groups, the stable trajectory group, including 92% of participants, and the changing trajectory group, including 8% of participants, were divided according to the group-based trajectory models. Compared with the stable trajectory group, the risk of developing preeclampsia in the changing trajectory group increased by 50.3% (OR = 1.502, 95%CI: 1.073, 2.105). Subgroup analysis showed positive association primarily in early-onset preeclampsia (OR: 3.859, CI: 2.293, 6.494) and severe preeclampsia (OR: 1.896, CI: 1.264, 2.844) subgroups. These findings can provide a direction to reduce the incidence of preeclampsia in twin pregnancies, considering growth discordance as a high-risk factor in clinical practice.

Uric acid, the final product of purine metabolism, plays a significant role in hypertension Research on uric acid has advanced significantly, particularly regarding its links to hypertension and cardiovascular disease (CVD). Our 2023 review covered the relationship between uric acid, hypertension; and CVD, however, numerous new studies have emerged since then. This paper provides an update, summarizing recent findings over the past two years on hyperuricemia and its association with hypertension, preeclampsia, arteriosclerosis, kidney disease, sleep-disordered breathing, CVD, and so on. Hyperuricemia, often driven by reduced uric acid excretion or increased production, is influenced by genetic factors and lifestyle habits, including high-purine foods, alcohol, and fructose intake. While hyperuricemia has been proposed to contribute to hypertension and CVD through mechanisms like inflammasome activation and oxidative stress, its causal role remains debated. Further clinical and basic science studies on hyperuricemia and purine metabolism are necessary to clarify its impact on CVD and guide therapeutic approaches.

Central blood pressure (BP) is more strongly associated with cardiovascular events than brachial BP. Few studies have described age-related changes in central BP in the general Japanese population. This study aimed to provide reference values for central BP parameters according to the age and sex, using data from 2964 participants aged 40-89 years (mean age: 60 years) who had no history of overt cardiovascular or chronic kidney disease and had not received antihypertensive, lipid-lowering, or hypoglycemic treatments. The central aortic pressure waveform was measured noninvasively by pulse wave analysis using the SphygmoCor XCEL operating system. Central systolic BP (cSBP), pulse pressure (cPP), and augmentation pressure (AP) exhibited a curvilinear relationship with age, with men having significantly higher cSBP but lower cPP and AP than women (cSBP: 132 mmHg vs. 123 mmHg, P < 0.001; cPP, 50 mmHg vs. 55 mmHg, P = 0.001; and AP: 24 mmHg vs. 32 mmHg, P = 0.002). Reference percentiles for cSBP, cPP, and AP were determined for each 5-year age group using the LMS method. Multiple regression analyses showed that age-standardized z-scores for cSBP, cPP, and AP were significantly associated with hypertension, dyslipidemia, diabetes mellitus, abdominal obesity, and heavy smoking, after adjusting for potential confounders. In conclusion, this study provides age- and sex-specific percentiles of central BP parameters in middle-aged and older Japanese adults. These reference values allow a more accurate interpretation of results and may be useful for diagnosis and management of hypertension in clinical practice and for risk stratification in population studies.

Primary aldosteronism (PA) is a prevalent and curable secondary hypertensive disorder that accounts for 5-13% of all hypertension cases. The prevalence of resistant hypertension, cerebral and cardiovascular diseases, and renal complications is higher in PA patients than in those with essential hypertension. Appropriate diagnosis and treatment at an early stage may suppress cerebral and cardiovascular events. Lifestyle modifications recommended for essential hypertensive patients, including dietary salt restriction and appropriate calorie intake to avoid fat accumulation, play a crucial role in suppressing overactivation of the mineralocorticoid receptor (MR), which helps to control blood pressure and prevent end-organ damage. Esaxerenone is a safe mineralocorticoid receptor antagonist (MRA) with strong antihypertensive and anti-albuminuric effects. Aldosterone synthase inhibitors (ASIs) have been developed, which are antihypertensive agents with a new mechanism of action. The pharmacological mechanisms of MRAs and ASIs differ; MRAs block MR activity by preventing aldosterone and/or cortisol from binding to the MR, while ASIs block aldosterone secretion from the adrenal gland. Other new treatments, such as robot-assisted laparoscopic adrenalectomy, percutaneous computed tomography radiofrequency ablation, transvenous radiofrequency catheter ablation, and super-selective adrenal arterial embolization have been developed. Further research will lead to better treatments for PA patients and reduce the frequency of cerebral and cardiovascular events.

Hypertensive disorders of pregnancy (HDP) are leading causes of maternal and infant mortality, and maternal age is a known factor influencing maternal and pediatric outcomes during childbirth. This study aimed to clarify the impact of maternal age-specific blood pressure (BP) and its patterns on the risk of HDP using data from a large nationwide study in Japan. This cohort study (N = 100,949) used data from the Japan Environment and Children's Study. The outcome variables in this study were HDP at each trimester of pregnancy. We stratified the participants into groups according to their age. The risk of HDP tended to be higher in women aged ≥35 years than in those aged <35 years, even at the same BP level. The BP patterns in the first and second trimesters of pregnancy showed a significantly increased risk of developing HDP at a higher BP in the first trimester, even when the BP in the second trimester was the same. The risk of HDP was equivalent in women aged <35 years and those aged≥ 35 years with an approximately 10 mmHg lower BP. In contrast, in women aged ≥35 years, a low diastolic BP in early pregnancy and pulse pressure (PP) > 60 mmHg significantly increased the risk of HDP. This large national cohort study indicates that the risk of HDP is associated with maternal age and PP in Japan. Early diagnosis of HDP can be achieved by focusing on the BP in the first trimester of pregnancy and PP.